An investigational new heart failure drug could be poised to change the face of cardiology based on Hot Line results presented today at ESC Congress 2014.
Findings from the PARADIGM-HF trial, published simultaneously in the New England Journal of Medicine, “are extraordinarily powerful and compelling; they are destined to change the management of patients with chronic heart failure for years to come,” said Milton Packer, MD, co-primary author of the study from University of Texas Southwestern Medical Center, in Dallas, Texas USA.
“This really is an astonishing result and a real breakthrough for patients with heart failure,” added John McMurray, MD, the other co-primary author, from the University of Glasgow, UK.
The new agent, an angiotensin receptor-neprilysin inhibitor (ARNI) known as LCZ696, has already been granted Fast Track status by the United States Food and Drug Administration (FDA) – a designation which can expedite the review of new medicines intended to treat serious or life-threatening conditions. Fast Track designation also allows for rolling submission in the US, which Novartis said it expects to complete by the end of 2014. The company said it aims to file in Europe in early 2015.
“To say that we are excited is an understatement. We are absolutely thrilled,” said Dr. Packer.
“Given the survival advantage of LCZ696 over currently available drugs, once this drug becomes available, it would be difficult to understand why physicians would continue to use traditional angiotensin converting-enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARB) for the treatment of heart failure.”
The Latest on: Heart failure
via Google News
The Latest on: Heart failure
- UA cardiologist to discuss heart failure at 33rd annual Green Valley lecture serieson January 11, 2020 at 2:00 pm
will kick off the 33rd annual Green Valley Lecture Series with a talk about heart failure. The free event begins at 10 a.m. Thursday, Jan. 16, at the Canoa Hills Recreation Center, 3660 S. Camino del ...
- ProHealth joins largest U.S. heart failure device clinical trialon January 10, 2020 at 7:10 am
One of your neighbors posted in Neighbor Posts. Click through to read what they have to say. (The views expressed in this post are the author’s own.) ...
- Congestive Heart Failure Took My Friend, And I Won't Say Goodbyeon January 10, 2020 at 5:58 am
PORTLAND, OR — The older you become, the more that you're supposed to let go of traditions from your childhood. Among those is the idea that you are "best friends" with someone. When you're in 4os or ...
- Machine-learning facilitates selection of a novel diagnostic panel of metabolites for the detection of heart failureon January 10, 2020 at 5:19 am
The metabolic derangement is common in heart failure with reduced ejection fraction (HFrEF). The aim of the study was to check feasibility of the combined approach of untargeted metabolomics and ...
- Heart diseases raise risk for kidney failure, study findson January 9, 2020 at 3:00 pm
Jan. 9 (UPI) --Having certain heart diseases may increase a person's risk for developing kidney failure, a new study has found. In an analysis published Thursday in the Journal of the American Society ...
- Heart Disease May Up Risk of Kidney Failureon January 9, 2020 at 2:59 pm
THURSDAY, Jan. 9, 2020 (HealthDay News) -- Heart disease may increase your odds for kidney failure, a new study finds. "Individuals with a history of cardiovascular disease should be recognized as a ...
- Heart disease linked to a higher risk of kidney failureon January 9, 2020 at 2:02 pm
New research indicates that cardiovascular diseases—including heart failure, atrial fibrillation, coronary heart disease, and stroke—are each linked with a higher risk of developing kidney failure.
- Congestive Heart Failure: Coughing Up This Colored Phlegm Could Be A Warning Signon January 9, 2020 at 6:34 am
Congestive heart failure can cause fluid accumulation in the lungs, which can lead to pink colored blood-tinged phlegm.
- Diabetes Independently Linked to Increased Heart Failureon January 9, 2020 at 6:25 am
Diabetes mellitus (DM) may be an independent risk factor for the development of heart failure (HF), a new population-based study suggests. Investigators followed 116 adults with diabetes and 232 ...
- Considerable scatter in the relationship between left atrial volume and pressure in heart failure with preserved left ventricular ejection fractionon January 9, 2020 at 2:40 am
The index for a target that can lead to improved prognoses and more reliable therapy in each heterogeneous patient with heart failure with preserved ejection fraction (HFpEF) remains to be defined. We ...
via Bing News